Nadejda Valtcheva

1.5k total citations
16 papers, 1.1k citations indexed

About

Nadejda Valtcheva is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nadejda Valtcheva has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Nadejda Valtcheva's work include Nitric Oxide and Endothelin Effects (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Renal and related cancers (2 papers). Nadejda Valtcheva is often cited by papers focused on Nitric Oxide and Endothelin Effects (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Renal and related cancers (2 papers). Nadejda Valtcheva collaborates with scholars based in Switzerland, Germany and United States. Nadejda Valtcheva's co-authors include Robert Feil, Susanne Feil, Martin Röcken, Jürgen Brück, Kamran Ghoreschi, Peter J. Wild, Aurelia Noske, Eva Alexander, Caishu Deng and Ina M. Jürgenliemk‐Schulz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Nadejda Valtcheva

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadejda Valtcheva Switzerland 12 508 274 209 171 169 16 1.1k
Ying Xiong China 22 529 1.0× 123 0.4× 134 0.6× 135 0.8× 281 1.7× 92 1.5k
Lei Zhan China 23 704 1.4× 212 0.8× 60 0.3× 147 0.9× 460 2.7× 55 1.4k
Akihiko Kudo Japan 25 715 1.4× 265 1.0× 69 0.3× 51 0.3× 61 0.4× 69 1.5k
Rive Sarfstein Israel 26 899 1.8× 202 0.7× 74 0.4× 43 0.3× 388 2.3× 51 1.5k
Jean-Louis Danan France 22 559 1.1× 93 0.3× 109 0.5× 112 0.7× 169 1.0× 41 1.0k
Hung‐Pei Tsai Taiwan 14 287 0.6× 140 0.5× 34 0.2× 86 0.5× 142 0.8× 68 732
Esw Ngan Hong Kong 27 868 1.7× 120 0.4× 83 0.4× 39 0.2× 215 1.3× 62 1.9k
Hua Teng China 18 570 1.1× 146 0.5× 33 0.2× 81 0.5× 266 1.6× 42 1.1k
Rika Miki Japan 16 452 0.9× 99 0.4× 54 0.3× 58 0.3× 128 0.8× 41 1.1k
Eugene T. Grygielko United States 14 851 1.7× 99 0.4× 59 0.3× 56 0.3× 79 0.5× 20 1.5k

Countries citing papers authored by Nadejda Valtcheva

Since Specialization
Citations

This map shows the geographic impact of Nadejda Valtcheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadejda Valtcheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadejda Valtcheva more than expected).

Fields of papers citing papers by Nadejda Valtcheva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadejda Valtcheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadejda Valtcheva. The network helps show where Nadejda Valtcheva may publish in the future.

Co-authorship network of co-authors of Nadejda Valtcheva

This figure shows the co-authorship network connecting the top 25 collaborators of Nadejda Valtcheva. A scholar is included among the top collaborators of Nadejda Valtcheva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadejda Valtcheva. Nadejda Valtcheva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wagner, Ulrich, Ulrike Camenisch, Kathrin Zimmermann, et al.. (2022). Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients. Journal of Molecular Diagnostics. 24(8). 935–954. 1 indexed citations
2.
Valtcheva, Nadejda, Bich Doan Nguyen-Sträuli, Ulrich Wagner, et al.. (2021). Setting a diagnostic benchmark for tumor BRCA testing: detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue – A pilot study. Experimental and Molecular Pathology. 123. 104705–104705. 1 indexed citations
3.
Wyvekens, Nicolas, Nadejda Valtcheva, Axel Mischo, et al.. (2020). Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Genes Chromosomes and Cancer. 59(11). 611–619. 21 indexed citations
4.
Rechsteiner, Markus, Nadejda Valtcheva, Sandra N. Freiberger, et al.. (2018). Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study. Pathology - Research and Practice. 214(4). 572–578. 15 indexed citations
5.
Valtcheva, Nadejda, Aurelia Noske, Eleftherios Pierre Samartzis, et al.. (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report. BMC Cancer. 17(1). 66–66. 11 indexed citations
6.
Britschgi, Christian, Markus Rechsteiner, Nadejda Valtcheva, et al.. (2017). Implications of routine NGS testing for daily clinical practice – the Zurich experience with the OFA panel. Annals of Oncology. 28. vii15–vii15. 1 indexed citations
7.
Noske, Aurelia, Simone Brandt, Nadejda Valtcheva, et al.. (2016). Detection ofCCNE1/URI(19q12) amplification byin situhybridisation is common in high grade and type II endometrial cancer. Oncotarget. 8(9). 14794–14805. 13 indexed citations
8.
Church, Dawn R., Ellen Stelloo, Nadejda Valtcheva, et al.. (2014). PROGNOSTIC SIGNIFICANCE OF POLE EXONUCLEASE DOMAIN MUTATION IN EARLY STAGE ENDOMETRIAL CANCER. Data Archiving and Networked Services (DANS).
9.
Church, David N., Ellen Stelloo, Remi A. Nout, et al.. (2014). Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer. JNCI Journal of the National Cancer Institute. 107(1). 402–402. 241 indexed citations
10.
Ikenberg, Kristian, Nadejda Valtcheva, Simone Brandt, et al.. (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. The Journal of Pathology. 234(2). 239–252. 24 indexed citations
11.
Valtcheva, Nadejda, et al.. (2013). The Orphan Adhesion G Protein-coupled Receptor GPR97 Regulates Migration of Lymphatic Endothelial Cells via the Small GTPases RhoA and Cdc42. Journal of Biological Chemistry. 288(50). 35736–35748. 45 indexed citations
12.
Hoetzenecker, Wolfram, Bernd Echtenacher, Emmanuella Guenova, et al.. (2011). ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nature Medicine. 18(1). 128–134. 158 indexed citations
13.
Ghoreschi, Kamran, Jürgen Brück, Christina Kellerer, et al.. (2011). Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. The Journal of Experimental Medicine. 208(11). 2291–2303. 295 indexed citations
14.
Feil, Susanne, Nadejda Valtcheva, & Robert Feil. (2009). Inducible Cre Mice. Methods in molecular biology. 530. 343–363. 184 indexed citations
15.
Valtcheva, Nadejda, Alexander Beck, Michael Russwurm, et al.. (2008). The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells. Journal of Biological Chemistry. 284(1). 556–562. 34 indexed citations
16.
Weber, Silke Anna Theresa, Dominik Bernhard, Robert Łukowski, et al.. (2007). Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle–Specific Expression of Either Isozyme. Circulation Research. 101(11). 1096–1103. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026